World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03147014
Date of registration: 04/05/2017
Prospective Registration: No
Primary sponsor: Beijing Anzhen Hospital
Public title: Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease
Scientific title: Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease
Date of first enrolment: January 1, 2016
Target sample size: 600
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT03147014
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
China
Contacts
Name:     Yihua He, MD
Address: 
Telephone:
Email:
Affiliation:  Beijing Anzhen Hospital
Name:     Wei Li, MD
Address: 
Telephone: +86 15901281629
Email: anzhenyuanban@163.com
Affiliation: 
Name:     Yanping Ruan, MD
Address: 
Telephone: +86 15311258732
Email: yanping.ruan@163.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- All singleton fetuses with CHD at all gestational ages are eligible for enrollment in
the study. Patients will be recruited to enroll in the study as they present for
clinical care at Fetal Echocardiography clinic. MH assessments will all be performed
only at the Beijing Anzhen Hospital. Baseline room air data for CHD may be collected
from other referring centers within the Anzhen network.

Exclusion Criteria:

- Non-sinus rhythm, presence of arrhythmia; Fetal hydrops; Severe brain anomaly (which
may influence MCA flow); Evidence for significant ventricular dysfunction; Evidence
for constriction of the ductus arteriosus



Age minimum: N/A
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Hypoplastic Left Heart Syndrome
Atrial Septal Aneurysm
Aortic Coarctation
Intervention(s)
Biological: Maternal hyperoxygenation
Primary Outcome(s)
MCA PI change before and after maternal hyperoxygenation [Time Frame: 10-15 minutes]
Secondary Outcome(s)
UA PI change before and after maternal hyperoxygenation [Time Frame: 10-15 minutes]
Secondary ID(s)
MH-FCHD01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history